Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — HeartSciences Inc.

Accession: 0001213900-26-081825

Filed: 2026-07-27

Period: 2026-07-27

CIK: 0001468492

SIC: 3842 (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES)

Item: Entry into a Material Definitive Agreement

Item: Financial Statements and Exhibits

Documents

8-K — ea0299240-8k_heart.htm (Primary)

EX-2.2 — AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER, DATED AS OF JULY 27, 2026, BY AND AMONG HEARTSCIENCES INC., CORDIS ACQUISITION, LLC, FORTITUDE MINING HOLDINGS, INC. AND FORTITUDE MINING HOLDCO, LLC (ea029924001ex2-2.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0299240-8k_heart.htm · Sequence: 1

false

0001468492

0001468492

2026-07-27

2026-07-27

0001468492

us-gaap:CommonStockMember

2026-07-27

2026-07-27

0001468492

HSCS:WarrantsMember

2026-07-27

2026-07-27

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities

Exchange Act of 1934

Date of Report (Date of earliest event reported):

July 27, 2026

HEARTSCIENCES INC.

(Exact name of Registrant as Specified in Its

Charter)

Texas

001-41422

26-1344466

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

550 Reserve Street, Suite 360

Southlake, Texas

76092

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including

Area Code: (682) 237-7781

(Former Name or Former Address, if Changed Since

Last Report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock

HSCS

The Nasdaq Stock Market LLC

Warrants

HSCSW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2

of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01. Entry into a Material Definitive Agreement.

On July 27, 2026, HeartSciences

Inc., a Texas corporation (“HeartSciences”), entered into Amendment No. 1 to the Agreement and Plan of Merger (the

“Amendment”) with Fortitude Mining Holdings, Inc., a Delaware corporation (“Seller”), Fortitude

Mining HoldCo, LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of Seller (“Fortitude”),

and Cordis Acquisition, LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of HeartSciences (“Merger

Sub”), which amends the previously announced Agreement and Plan of Merger, dated June 23, 2026 (the “Original Merger

Agreement” and the Original Merger Agreement as amended, supplemented or otherwise modified by the Amendment, the “Amended

Merger Agreement”), entered into by and among HeartSciences, Seller, Fortitude and Merger Sub. Capitalized terms used but not

defined herein shall have the meanings ascribed to them in the Amended Merger Agreement.

The Amendment amends the Original

Merger Agreement to, among other things, (i) replace the form of A&R LLC Agreement to clarify certain redemption mechanics, and (ii)

replace the form of Parent New Charter to provide for a proposed amendment to the requirements for HeartSciences shareholder action by

written consent.

The foregoing description

of the Amendment and the Amended Merger Agreement is not complete and is qualified in its entirety by reference to the Amendment, which

is filed as Exhibit 2.1 to this Current Report on Form 8-K and incorporated herein by reference and the Original Merger Agreement, which

is attached as Exhibit 2.1 to the previously filed Current Report on Form 8-K, filed by HeartSciences on June 23, 2026 with the U.S. Securities

and Exchange Commission (the “SEC”) and incorporated herein by reference.

Additional Information and

Where to Find It

HeartSciences intends to file

with the SEC a proxy statement (together with any amendments or supplements thereto, the “Proxy Statement”) in connection

with the transactions contemplated by the Amended Merger Agreement (the “Transactions”). The definitive Proxy Statement

and other relevant documents will be mailed to stockholders of HeartSciences as of a record date to be established for voting on the Transactions

and other matters as described in the Proxy Statement. HeartSciences will also file other documents regarding the Transactions with the

SEC. This Current Report does not contain all of the information that should be considered concerning the Transactions and is not intended

to form the basis of any investment decision or any other decision in respect of the Transactions. BEFORE MAKING ANY VOTING OR INVESTMENT

DECISION, STOCKHOLDERS OF HEARTSCIENCES AND OTHER INTERESTED PARTIES ARE URGED TO READ, WHEN AVAILABLE, THE PRELIMINARY PROXY STATEMENT,

AND AMENDMENTS THERETO, AND THE DEFINITIVE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN

CONNECTION WITH HEARTSCIENCES’ SOLICITATION OF PROXIES FOR THE SPECIAL MEETING OF ITS STOCKHOLDERS TO BE HELD TO APPROVE THE TRANSACTIONS

AND OTHER MATTERS AS DESCRIBED IN THE PROXY STATEMENT BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION ABOUT HEARTSCIENCES AND

FORTITUDE AND THE TRANSACTIONS. Investors and security holders will also be able to obtain copies of the Proxy Statement and all other

documents filed or that will be filed with the SEC by HeartSciences, without charge, once available, on the SEC’s website at www.sec.gov.

NEITHER THE SEC NOR ANY STATE

SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED HEREIN, PASSED UPON THE MERITS OR FAIRNESS OF THE

TRANSACTIONS OR ANY RELATED TRANSACTIONS OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THIS CURRENT REPORT. ANY REPRESENTATION

TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE.

1

Participants in the Solicitation

HeartSciences, Seller, Fortitude

and their respective directors and executive officers, and certain executive officers of Digital Currency Group, Inc., the sole stockholder

of Seller, may be deemed under SEC rules to be participants in the solicitation of proxies from HeartSciences’ stockholders in connection

with the Transactions. A list of the names of such persons, and information regarding their interests in the Transactions and their ownership

of HeartSciences’ securities are, or will be, contained in HeartSciences’ filings with the SEC, including HeartSciences’

Annual Report on Form 10-K for the year ended April 30, 2026 filed with the SEC on July 23, 2026. Additional information regarding the

interests of the persons who may, under SEC rules, be deemed participants in the solicitation of proxies of HeartSciences’ stockholders

in connection with the Transactions, including the names and interests of HeartSciences’, Seller’s and Fortitude’s respective

directors and executive officers, will be set forth in the Proxy Statement and other relevant materials, which are expected to be filed

by HeartSciences with the SEC when they become available. Investors and security holders may obtain free copies of these documents as

described above.

No Offer or Solicitation

The information contained

in this Current Report and the exhibits filed or furnished herewith are for informational purposes only and are not a proxy statement

or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Transactions and shall not constitute

an offer to sell or exchange, or a solicitation of an offer to buy or exchange the securities of HeartSciences, or any commodity or instrument

or related derivative, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation,

sale or exchange would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No

offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act or an exemption therefrom.

Investors should consult with their counsel as to the applicable requirements for a purchaser to avail itself of any exemption under the

Securities Act.

Item 9.01 Financial Statements and Exhibits

Number

Description

2.1

Merger Agreement, dated as of June 23, 2026, among HeartSciences Inc., Fortitude Mining Holdings, Inc., Fortitude Mining HoldCo, LLC and Cordis Acquisition, LLC (incorporated by reference to Exhibit 2.1 to HeartSciences’ Current Report on Form 8-K, filed with the SEC on June 23, 2026)

2.2*

Amendment No. 1 to Agreement and Plan of Merger, dated as of July 27, 2026, by and among HeartSciences Inc., Cordis Acquisition, LLC, Fortitude Mining Holdings, Inc. and Fortitude Mining HoldCo, LLC.

104**

Cover Page Interactive Data File (embedded within the Inline XBRL document).

*

Filed herewith.

**

Furnished herewith.

2

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

HEARTSCIENCES INC.

Date: July 27, 2026

By:

/s/ Andrew Simpson

Name:

Andrew Simpson

Title:

President, Chief Executive Officer and Chairman of the Board of Directors

3

EX-2.2 — AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER, DATED AS OF JULY 27, 2026, BY AND AMONG HEARTSCIENCES INC., CORDIS ACQUISITION, LLC, FORTITUDE MINING HOLDINGS, INC. AND FORTITUDE MINING HOLDCO, LLC

EX-2.2

Filename: ea029924001ex2-2.htm · Sequence: 2

Exhibit 2.2

Execution

Version

AMENDMENT

No. 1 to MERGER Agreement

This AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER,

dated as of July 27, 2026 (this “Amendment”), is made by and among HeartSciences Inc., a Texas corporation (“Parent”),

Cordis Acquisition, LLC, a Delaware limited liability company and a direct, wholly-owned Subsidiary of Parent (“Merger Sub”),

Fortitude Mining Holdings, Inc., a Delaware corporation (“Seller”), and Fortitude Mining HoldCo, LLC, a Delaware limited

liability company and a direct, wholly-owned Subsidiary of Seller (“Fortitude”, and together with Parent, Merger Sub

and Seller, the “Parties”). Capitalized terms used but not specifically defined herein shall have the meanings ascribed

to such terms in the Merger Agreement (as defined below).

WHEREAS, Parent, Merger Sub, Seller and Fortitude

are parties to the Agreement and Plan of Merger, dated as of June 23, 2026 (the “Merger Agreement”);

WHEREAS, pursuant to Section 10.13 of the Merger

Agreement, the Merger Agreement may be amended by an instrument in writing signed on behalf of each of the Parties; and

WHEREAS, the Parties desire to amend the Merger

Agreement as set forth herein.

NOW, THEREFORE, in consideration of the foregoing

and the covenants and agreements herein contained, and for other good and valuable consideration, the receipt and sufficiency of which

are hereby acknowledged, the Parties agree as follows:

1. Effective

as of the date of this Amendment, the Merger Agreement is hereby amended as follows:

(a) Exhibit

A (Form of A&R LLC Agreement) to the Merger Agreement is hereby deleted in its entirety and replaced with Annex A attached

hereto.

(b) Exhibit

E (Form of Parent New Charter) to the Merger Agreement is hereby deleted in its entirety and replaced with Annex B attached

hereto;

(c) Section

2.01(a) of the Merger Agreement shall be amended and restated in its entirety as follows:

“Conversion of Fortitude Non-Voting Units. Each

Fortitude Non-Voting Unit issued and outstanding immediately prior to the Effective Time shall be converted into the right to receive

a number of non-voting units of the Surviving Company (each, a “Surviving Company Non-Voting Unit” and, collectively,

“Surviving Company Units”) equal to (x) (i) the Closing Parent Common Stock Shares, multiplied by (ii)

the Exchange Ratio, divided by (y) the number of Fortitude Non-Voting Units issued and outstanding immediately prior to the Effective

Time (collectively, the “Merger Consideration”). The Merger Consideration issued (and paid) in accordance with the

terms of this Article II upon conversion of any Fortitude Non-Voting Units will be deemed to have been issued (and paid) in full

satisfaction of all rights pertaining to such Fortitude Non-Voting Units.”

(d) The

following shall be added as new Section 2.06 of the Merger Agreement:

“Section 2.06.  Certain Adjustments. If,

during the period between the date of this Agreement and the Effective Time, any change in Parent Common Stock shall occur as a result

of any reverse stock split with a record date during such period, the Merger Consideration, the Fortitude Voting Unit Contribution Consideration,

the Fortitude Property Contribution Consideration, the Fortitude Property Contribution, the Exchange Ratio and the Closing Parent Common

Stock VWAP shall be appropriately adjusted to eliminate the effect of such event on the Merger Consideration, the Fortitude Voting Unit

Contribution Consideration, the Fortitude Property Contribution Consideration, the Fortitude Property Contribution, the Exchange Ratio

or the Closing Parent Common Stock VWAP.”

2. All

of the provisions of this Amendment shall be effective as of the date of this Amendment. Except as otherwise specifically amended, modified

or supplemented by this Amendment, all terms of the Merger Agreement shall remain unchanged and continue in full force and effect until

the expiration or earlier termination of the Merger Agreement unless the same be otherwise sooner amended. From and after the date hereof,

each reference in the Merger Agreement to “this Agreement,” “hereof,” “hereunder”, “herein”

or words of like import, and all references to the Merger Agreement and all agreements, instruments, documents, notes, certificates and

other writings of every kind or nature that refer to the Merger Agreement will be deemed to mean the Merger Agreement as modified by this

Amendment, whether or not this Amendment is expressly referenced; provided, that references in the Merger Agreement to “as

of the date hereof” or “as of the date of this Agreement” or words of like import shall continue to refer to the date

of June 23, 2026.

3. Article

X (General Provisions) of the Merger Agreement is incorporated herein by reference and shall apply mutatis mutandis to

this Amendment.

[The remainder of this page

is intentionally left blank.]

IN WITNESS WHEREOF, the Parties

hereto have caused this Agreement to be executed by their respective officers thereunto duly authorized as of the date first above written.

HEARTSCIENCES INC.

By:

/s/ Andrew Simpson

Name:

Andrew Simpson

Title:

Chief Executive Officer

CORDIS ACQUISITION, LLC

By:

/s/ Andrew Simpson

Name:

Andrew Simpson

Title:

Chief Executive Officer

FORTITUDE MINING HOLDINGS, INC.

By:

/s/ Andrea Childs

Name:

Andrea Childs

Title:

Chief Executive Officer

FORTITUDE MINING HOLDCO, LLC

By:

Fortitude Mining Holdings, Inc., its sole member

By:

/s/ Andrea Childs

Name:

Andrea Childs

Title:

Chief Executive Officer

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Jul. 27, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 27, 2026

Entity File Number

001-41422

Entity Registrant Name

HEARTSCIENCES INC.

Entity Central Index Key

0001468492

Entity Tax Identification Number

26-1344466

Entity Incorporation, State or Country Code

TX

Entity Address, Address Line One

550 Reserve Street

Entity Address, Address Line Two

Suite 360

Entity Address, City or Town

Southlake

Entity Address, State or Province

TX

Entity Address, Postal Zip Code

76092

City Area Code

682

Local Phone Number

237-7781

Written Communications

false

Soliciting Material

true

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Common Stock [Member]

Title of 12(b) Security

Common Stock

Trading Symbol

HSCS

Security Exchange Name

NASDAQ

Warrants

Title of 12(b) Security

Warrants

Trading Symbol

HSCSW

Security Exchange Name

NASDAQ

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type:

X

- Details

Name:

us-gaap_StatementClassOfStockAxis=HSCS_WarrantsMember

Namespace Prefix:

Data Type:

na

Balance Type:

Period Type: